Highly glycosylated tumour antigens: Interactions with the immune system

Biochemical Society Transactions

Volumn 39, Issue 1, 2011, Pages 388-392

  Saeland, Eirikur ^a   Van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C type lectin; Cancer; Carcinoembryonic antigen (CEA); Dendritic cell; Glycosylation; Mucin

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; LECTIN RECEPTOR; LECTIN RECEPTOR C TYPE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; CELL TRANSFORMATION; CONFERENCE PAPER; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GLYCOSYLATION; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIGENS, NEOPLASM; DENDRITIC CELLS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNE SYSTEM; NEOPLASMS; OLIGOSACCHARIDES; POLYSACCHARIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 79551484543     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390388     Document Type: Conference Paper

References (50)

1. Ohtsubo, K. and Marth, J.D. (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867
2. Cooper, H.S. and Haesler, Jr, W.E. (1978) Blood group substances as tumor antigens in the distal colon. Am. J. Clin. Pathol. 69, 594-598
3. Madjd, Z., Parsons, T., Watson, N.F., Spendlove, I., Ellis, I. and Durrant, L.G. (2005) High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res. 7, R780-R787
4. Nakayama, T., Watanabe, M., Katsumata, T., Teramoto, T. and Kitajima, M. (1995) Expression of sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75, 2051-2056
5. x and mRNA transcripts of the core 2 β-1,6-N- acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer 9, 79
6. Drake, P.M., Cho, W., Li, B., Prakobphol, A., Johansen, E., Anderson, N.L., Regnier, F.E., Gibson, B.W. and Fisher, S.J. (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 56, 223-236
7. Brooks, S.A. and Leathem, A.J. (1991) Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Lancet 338, 71-74
8. Fenlon, S., Ellis, I.O., Bell, J., Todd, J.H., Elston, C.W. and Blamey, R.W. (1987) Helix pomatia and Ulex europaeus lectin binding in human breast carcinoma. J. Pathol. 152, 169-176
9. Seelentag, W.K., Li, W.P., Schmitz, S.F., Metzger, U., Aeberhard, P., Heitz, P.U. and Roth, J. (1998) Prognostic value of β1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res. 58, 5559-5564
10. Hammarstrom, S. (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9, 67-81
11. Meany, D.L., Zhang, Z., Sokoll, L.J., Zhang, H. and Chan, D.W. (2009) Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. J. Proteome Res. 8, 613-619
12. Moss, E.L., Hollingworth, J. and Reynolds, T.M. (2005) The role of CA125 in clinical practice. J. Clin. Pathol. 58, 308-312
13. Duffy, M.J., Duggan, C., Keane, R., Hill, A.D., McDermott, E., Crown, J. and O'Higgins, N. (2004) High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer. Clin. Chem. 50, 559-563
14. Patton, S., Gendler, S.J. and Spicer, A.P. (1995) The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim. Biophys. Acta 1241, 407-423
15. Gendler, S.J. (2001) MUC1, the renaissance molecule. J. Mamm. Gland Biol. Neoplasia 6, 339-353
16. Ho, S.B. and Kim, Y.S. (1991) Carbohydrate antigens on cancer-associated mucin-like molecules. Semin. Cancer Biol. 2, 389-400
17. Lloyd, K.O., Burchell, J., Kudryashov, V., Yin, B.W. and Taylor-Papadimitriou, J. (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines: demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 271, 33325-33334
18. Beauchemin, N., Benchimol, S., Cournoyer, D., Fuks, A. and Stanners, C.P. (1987) Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen. Mol. Cell. Biol. 7, 3221-3230
19. + T cells by intestinal epithelial cells. Ann. N.Y. Acad. Sci. 1029, 22-35
20. Ordonez, C., Screaton, R.A., Ilantzis, C. and Stanners, C.P. (2000) Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res. 60, 3419-3424
21. Crawford, N.P., Colliver, D.W. and Galandiuk, S. (2003) Tumor markers and colorectal cancer: utility in management. J. Surg. Oncol. 84, 239-248
22. Shao, L., Allez, M., Park, M.S. and Mayer, L. (2006) Immunomodulatory roles of the carcinoembryonic antigen family of glycoproteins. Ann. N.Y. Acad. Sci. 1072, 194-209
23. Nichols, E.J., Kannagi, R., Hakomori, S.I., Krantz, M.J. and Fuks, A. (1985) Carbohydrate determinants associated with carcinoembryonic antigen (CEA). J. Immunol. 135, 1911-1913
24. Yamashita, K., Totani, K., Kuroki, M., Matsuoka, Y., Ueda, I. and Kobata, A. (1987) Structural studies of the carbohydrate moieties of carcinoembryonic antigens. Cancer Res. 47, 3451-3459
25. Kim, Y.J. and Varki, A. (1997) Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconjugate J. 14, 569-576
26. Banchereau, J. and Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252
27. van Kooyk, Y. and Rabinovich, G.A. (2008) Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9, 593-601
28. Zelensky, A.N. and Gready, J.E. (2005) The C-type lectin-like domain superfamily. FEBS J. 272, 6179-6217
29. van Gisbergen, K.P., Aarnoudse, C.A., Meijer, G.A., Geijtenbeek, T.B. and van Kooyk, Y. (2005) Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 65, 5935-5944
30. van Vliet, S.J., van Liempt, E., Saeland, E., Aarnoudse, C.A., Appelmelk, B., Irimura, T., Geijtenbeek, T.B., Blixt, O., Alvarez, R., van Die, I. and van Kooyk, Y. (2005) Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int. Immunol. 17, 661-669
31. Garcia-Vallejo, J.J. and van Kooyk, Y. (2009) Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol. Rev. 230, 22-37
32. Saeland, E., van Vliet, S.J., Backstrom, M., Van Den Berg, V., Geijtenbeek, T.B., Meijer, G.A. and van Kooyk, Y. (2007) The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol. Immunother. 56, 1225-1236
33. Napoletano, C., Rughetti, A., Gervig Tarp, M.P., Coleman, J., Bennett, E.P., Picco, G., Sale, P., da-Nagai, K., Irimura, T., Mandel, U. et al. (2007) Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res. 67, 8358-8367
34. Geijtenbeek, T.B. and Gringhuis, S.I. (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465-479
35. Gringhuis, S.I., den Dunnen, J., Litjens, M., van het Hof, B., van Kooyk, Y. and Geijtenbeek, T.B. (2007) C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26, 605-616
36. Tacken, P.J., de Vries, I., Gijzen, K., Joosten, B., Wu, D., Rother, R.P., Faas, S.J., Punt, C.J., Torensma, R., Adema, G.J. and Figdor, C.G. (2005) Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106, 1278-1285
37. Singh, S.K., Stephani, J., Schaefer, M., Kalay, H., Garcia-Vallejo, J.J., den Haan, J., Saeland, E., Sparwasser, T. and van Kooyk, Y. (2009) Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol. Immunol. 47, 164-174
38. + mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol. Immunother. 56, 1459-1469
39. Iwamoto, M., Shinohara, H., Miyamoto, A., Okuzawa, M., Mabuchi, H., Nohara, T., Gon, G., Toyoda, M. and Tanigawa, N. (2003) Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int. J. Cancer 104, 92-97
40. Lin, A., Schildknecht, A., Nguyen, L.T. and Ohashi, P.S. (2010) Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol. Lett. 127, 77-84
41. Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D. et al. (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10, 48-54
42. Singh, S.K., Streng-Ouwehand, I., Litjens, M., Weelij, D.R., Garcia-Vallejo, J.J., van Vliet, S.J., Saeland, E. and van Kooyk, Y. (2009) Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties. Mol. Immunol. 46, 1240-1249
43. Tsuiji, M., Fujimori, M., Ohashi, Y., Higashi, N., Onami, T.M., Hedrick, S.M. and Irimura, T. (2002) Molecular cloning and characterization of a novel mouse macrophage C-type lectin, mMGL2, which has a distinct carbohydrate specificity from mMGL1. J. Biol. Chem. 277, 28892-28901
44. Singh, S.K., Streng-Ouwehand, I., Litjens, M., Kalay, H., Saeland, E. and van Kooyk, Y. (2010) Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses. Int. J. Cancer, doi:10.1002/ijc.25458
45. van Vliet, S.J., van Liempt, E., Geijtenbeek, T.B. and van Kooyk, Y. (2006) Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology 211, 577-585
46. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H. et al. (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803-2808
47. Dwek, M.V., Jenks, A. and Leathem, A.J. (2010) A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate-specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia. Clin. Chim. Acta 411, 1935-1939
48. Matsumoto, H., Shinzaki, S., Narisada, M., Kawamoto, S., Kuwamoto, K., Moriwaki, K., Kanke, F., Satomura, S., Kumada, T. and Miyoshi, E. (2010) Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer. Clin. Chem. Lab. Med. 48, 505-512
49. Fukushima, K., Satoh, T., Baba, S. and Yamashita, K. (2010) α1,2-Fucosylated and β-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer. Glycobiology 20, 452-460
50. Taylor, M.E. and Drickamer, K. (2009) Structural insights into what glycan arrays tell us about how glycan-binding proteins interact with their ligands. Glycobiology 19, 1155-1162